Catalyst Wire Dossier Catalyst Wire Dossier

Laflavon

· Omicron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Laflavon, covering 2011-02-10 to 2011-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL) [Phase 3]

See pricing